A short story by the Weizmann Institute of Science's Peter Tsvetkov and Tel-Aviv University's Sharon Dekel posted at LabLit this week details a personified p53's visit with a "gene therapist." The transcription factor, it seems, is at odds with his roles in cancer and apoptosis. "When I was first discovered they accused me of being oncogenic, accused me of supporting cancer. It took them many years to understand that I am the good guy, that I'm a tumor suppressor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.